Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ensysce Biosciences Inc. (ENSC)

  • Business News
  • Jan. 21, 2026, 13:00 UTC
  • 2
  • 1 comments

Ensysce Biosciences Expands Global Opioid Patent Portfolio

Market reaction Comment Full text

Curaleaf Hldgs Inc. (CURLF)

  • Business News
  • Jan. 21, 2026, 12:45 UTC
  • 1
  • 1 comments

Curaleaf Celebrates Launch of Adult-Use Sales in Maine at Bangor Dispensary

Market reaction Comment Full text

Agenus Inc. (AGEN)

  • Business News
  • Jan. 21, 2026, 12:30 UTC
  • 2
  • 1 comments

Agenus Inc. - Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab

Market reaction Comment Full text

Brainsway Ltd (BWAY)

  • Business News
  • Jan. 21, 2026, 12:30 UTC
  • 0
  • 1 comments

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

Market reaction Comment Full text

Venus Concept Inc (VERO)

  • Business News
  • Jan. 21, 2026, 12:30 UTC
  • 2
  • 1 comments

Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC

Market reaction Comment Full text

Bausch Health Companies Inc (BHC)

  • Business News
  • Jan. 21, 2026, 12:03 UTC
  • 0
  • 1 comments

Bausch Health Notification

Market reaction Comment Full text

Exicure Inc. (XCUR)

  • Business News
  • Jan. 21, 2026, 12:01 UTC
  • 0
  • 1 comments

Exicure, Inc. - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

Market reaction Comment Full text

Quidel Corporation (QDEL)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 0
  • 1 comments

QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Market reaction Comment Full text

Quidel Corporation (QDEL)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 0
  • 1 comments

QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Market reaction Comment Full text

Ocular Therapeutix Inc (OCUL)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 0
  • 1 comments

Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

Market reaction Comment Full text
  • Previous
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next

Search

News categories

  • Technical Exchange News(10841)
  • Event(2204)
  • SEC News(187803)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124251)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin